Definium Therapeutics, Inc. (DFTX)
↓ Download CSVKey ratios (FY2025)
-55.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$166.31M | -$103.92M | -$93.87M | -$66.33M | -$93.85M | -$33.03M | — |
| Net Income | -$183.79M | -$108.68M | -$95.73M | -$56.80M | -$93.04M | -$33.94M | — |
| EPS (Diluted) | $-2.06 | $-1.54 | $-2.44 | $-1.84 | $-3.40 | — | — |
| Total Assets | $440.10M | $302.15M | $124.54M | $169.99M | $164.00M | $81.52M | — |
| Total Liabilities | $107.77M | $60.70M | $46.41M | $19.08M | $12.34M | $5.65M | — |
| Shareholders' Equity | $332.33M | $241.45M | $78.13M | $150.92M | $151.66M | $75.87M | $4.78M |
| Cash & Equivalents | $257.84M | $273.74M | $99.70M | $142.14M | $133.54M | $80.09M | — |
| Operating Cash Flow | -$131.56M | -$79.13M | -$64.36M | -$50.14M | -$45.82M | -$23.60M | — |
| Shares Outstanding | 98.78M | 75.10M | 41.10M | 37.98M | 28.13M | — | — |